Bank Of New York Mellon Corp Sensei Biotherapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.49 - $2.3 $80,592 - $124,404	-54,089 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$2.22 - $6.07 $3,014 - $8,243	-1,358 Reduced 2.45%	54,089 $126,000
Q4 2021 Feb 11, 2022	BUY	$4.85 - $10.48 $40,647 - $87,832	8,381 Added 17.81%	55,447 $322,000
Q3 2021 Nov 12, 2021	BUY	$6.89 - $11.99 $197,295 - $343,333	28,635 Added 155.36%	47,066 $495,000
Q2 2021 Aug 11, 2021	BUY	$9.1 - $15.14 $39,757 - $66,146	4,369 Added 31.07%	18,431 $179,000
Q1 2021 May 13, 2021	BUY	$12.04 - $22.75 $169,306 - $319,910	14,062 New	14,062 $204,000

2.39M

Ticker SNSE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,720,300
Market Cap $11.7M
Description
Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune res...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.